Macrophage polarization in wound healing: A review of the M1/M2 axis
[DOI] [PMC free article] [PubMed] [Google Scholar] 70.Sanchez-Roige S., Palmer A.A., Fontanillas P., Elson S.L., 23andMe Research Team
Given the pre-existing data on GLP-1 and glucagon, we designed a double-blinded randomised cross-over study, in which we gave volunteers who were overweight short-term intravenous infusions of glucagon (50 ng/kg/min or 14 pmol/kg/min), GLP-1 (0.8 pmol/kg/min), combination of glucagon + GLP-1 at the same doses, or placebo over 45 minutes, and demonstrated that there was a significant increase in resting energy expenditure with glucagon alone which was preserved with the combination of glucagon + GLP-1, whereas GLP-1 did not affect energy expenditure (66)
I know my skin is in good hands
You see: New patients who are early in their obesity treatment journey People with prior diet fatigue who want a more durable tool Patients with cardiometabolic risk who are trying to intervene earlier Users who are already thinking about maintenance, not just short-term weight loss That matters because the evidence base starts to reflect real demand